0001127602-16-051294.txt : 20160505
0001127602-16-051294.hdr.sgml : 20160505
20160505203701
ACCESSION NUMBER: 0001127602-16-051294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160503
FILED AS OF DATE: 20160505
DATE AS OF CHANGE: 20160505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patton Cynthia M
CENTRAL INDEX KEY: 0001560565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 161625656
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-05-03
0000318154
AMGEN INC
AMGN
0001560565
Patton Cynthia M
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP & CCO
Common Stock
2016-05-03
4
A
0
1023
0
A
21901
D
Common Stock
241.8647
I
401(k) Plan
Nqso (Right to Buy)
156.35
2016-05-03
4
A
0
8711
0
A
2018-05-03
2026-05-03
Common Stock
8711
8711
D
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.
These shares include the following RSUs granted under the Company's equity plans: 1,843 RSUs which vest on 10/26/2016; 716 RSUs which vest on 1/28/2017; 732 RSUs which vest in one installment of 360 on 1/31/2017 and one installment of 372 on 1/31/2018; 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019; and 1,023 shares that vest in installments of 337 on 5/3/2018, 338 on 5/3/2019 and 348 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 236 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.
/s/ Cynthia M. Patton
2016-05-05